Answers are grounded in this paper and cite their sources.
Older adults represent a large and steadily growing proportion of patients receiving oncological care. At the same time, this group is inadequately represented in clinical trials [1]. Trial populations are almost invariably younger than the overall population of individuals with cancer, thereby limiting the generalizability of study results to real-world patients and especially older patients with cancer [2].
No takes yet. Share an insight, caveat, or question.
Kapitza et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: